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A b s t r A c t
ObJEctIVE Nowadays, the application of DNA-typing in laboratory medicine is in-
creasing rapidly for paternity/maternity disputes. The goal of this study was to evalu-
ate the use of polymorphic microsatellite marker DNA analysis and to establish this 
analysis as the method of choice for parentage investigations.
sUbJEcts AND MEtHODs Among 708 civil parentage tests addressed to our Labo-
ratory previously examined for HLA class I (-A*, -B*, -Cw*), and class II (-DRB1*, 
-DQB1*, -DPB1*) alleles using PCR-SSOP and/or PCR-SSP methodologies, a co-
hort of 50 cases (137 individuals) of disputed parentage was selected. In these cases 
DNA-typing was generated from co-amplification of 15 autosomal STR DNA mark-
ers (D3S1358, HUMTH01, D21S11, D18S51, Penta E, D5S818, D13S317, D7S820, 
D16S539, HUMCSF1PO, Penta D, HUMvWA, D8S1179, HUMTPOX, HUMFGA 
and the sex determining Amelogenin marker HUMAMEL), using fragment analysis 
methodology. 
rEsULts The evaluation of the results showed that 15 out of 50 cases were sufficient 
for exclusion of fatherhood by both approaches (HLA and STRs). In all remaining 35 
non-excluded cases, the PI value using HLA genotyping ranged from 76 to 6,452,794, 
whereas using aSTR genotyping ranged from 15,173 to 9.2×1010. In one non-excluded 
motherless case the alleged father showed one genetic discrepancy with the child at 
D21S11 locus, due to a mutation event. 
cONcLUsION The use of DNA-typing with 15 aSTR loci for parentage testing pro-
vides an accurate and high-sensitivity method which is simpler to perform and more 
rapid than an accepted standard technology, such as HLA genotyping. The analysis 
of aSTR loci offers a highly discriminating test suitable for trio paternity testing, in-
creasing the W rate in comparison to HLA genotyping. Nevertheless, when a muta-
tion event occurs in motherless cases, combination of HLA and STR polymorphisms 
offers high level of information, and also diminishes the possibility of false exclusion 
due to aSTRs mutations.
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I N t r O D U c t I O N
The need to establish family relationships arises not only 
for medical reasons (genetic counselling), but mainly in foren-
sics for human identity testing, disaster victim identifications, 
as well as in parentage disputes.1 Nowadays, the progress of 
the molecular techniques have greatly contributed to evaluate 
the relatedness between individual kinship analysis and civil 
parentage assessments, leading to solving the most complex 
cases, with high discriminating power.2 
For a long time determination of the major histocompat-
ibility complex in humans (MHC), known as human leukocyte 
antigen (HLA) region represented the standard procedure in 
forensic genetics. MHC is known as a cluster of genetic mark-
ers and consists of more than 220 genes of diverse function, 
encoded in a 3500 kbp segment on the short arm of chromo-
some 6p21.31.3,4 With the introduction of DNA based methods 
of HLA typing, extensive molecular polymorphism has been 
discovered in each of the relevant HLA class I (HLA-A*, HLA-
B*, HLA-Cw*) and class II (HLA-DRB1*, HLA-DQB1*, 
HLA-DPB1*) loci.5,6 According to the World Health Organiza-
tion Nomenclature Committee more than 13.700 HLA alleles 
have been documented in the international ImMunoGeneTics 
(IMGT/HLA database, http://www.ebi.ac.uk/imgt/hla re-
leased 3.22.0, 2015-10-10).7 MHC loci are located on the short 
arm of human chromosome 6, and an individual inherits two 
alleles of each of the above loci, one each from either parent, 
according to Mendelian fashion. Due to their close proxim-
ity, a complete set of alleles of genes mapped in a row to the 
same chromosome is usually inherited as an haplotype, apart 
from the recombination events (crossing over).8 However, in 
some complex paternity testing or deficiency cases, HLA typ-
ing could not provide enough discrimination power due to the 
linkage disequilibrium phenomenon and the predominance of 
certain HLA alleles in particular ethnic groups. The last two 
decades, new molecular markers located in the microsatellite 
regions have been introduced in the field of human identifica-
tion in order the above problems to be solved.9,10
Microsatellites, also called short tandem repeat (STR) loci, 
are highly informative markers found in the eukaryotic nuclear 
genome in both coding and noncoding regions. They are de-
fined as tandem repeats of 2-6 bp units and may be present 
as perfect or imperfect repeats. The number of repeats found 
in each individual are highly variable with as few as two, or as 
many as 50, copies in each microsatellite unit, depending on 
the locus, making these genetic markers effective for human 
identification purposes (details of published STR studies 
http://www.cstl.nist.gov/div831/strbase). During the past 
decade STR loci became a valuable tool in parentage investiga-
tions due to their high polymorphism and heterozygosity.11,12 
Nonetheless, STR loci are highly mutable as compared with 
point mutations in coding genes and mutation rates range 
from 10-6 to 10-2 events per locus per generation. These rates 
are highly affected by multiple factors such as repeat number, 
repeat unit, repeat structure, flanking sequence, sex, and 
age.13,14 According to the American Association of Blood Banks 
(AABB) guidelines, for parentage investigations, the criterion 
of power of exclusion is at least two incompatibilities to report 
exclusion of an alleged father.15 However, the last years the 
use of STR loci has replaced the HLA typing, as the method 
of choice for parentage testing. 
In the present study, 50 cases of disputed parentage (37 
trios, and 13 motherless cases), already evaluated by HLA 
typing, were retrieved from the archived records of the Immu-
nology and Histocompatibility Department of “Evangelismos” 
General Hospital and investigated by the new technology 
(“DNA profiling” based on STRs loci polymorphism). The 
aim was to investigate and compare the usefulness of these 
two systems (HLA and STRs), and to discuss the advantages 
and drawbacks of each of these two methodologies in disputed 
paternity testing.
s U b J E c t s  A N D  M E t H O D s
1 .  s A M P L E  c O L L E c t I O N  A N D  D N A  E X t r A c t I O N
Among 708 civil parentage tests addressed to our Labora-
tory, a cohort of 50 paternity cases, some in deficiency, was 
selected, including 37 trios consisted of the mother, one child 
and one alleged father and 13 duos consisted of one child and 
one alleged father (motherless cases). The process of recording 
and archiving of samples, as well as the privacy procedure, were 
carried out following the guidelines of the human and ethical 
research principles. Additionally, the informed consent for 
genetic studies was obtained from all participants. Peripheral 
blood samples (drawn in sodium citrate 2%) were obtained 
by venipuncture from 137 individuals, all of Greek origin. 
Genomic DNA was isolated from peripheral blood leukocytes 
of all individuals by automated purification procedure, using 
the Maxwell® 16 instrument (extractor) and the Maxwell® 16 
Blood DNA Purification kit (Promega Corporation, Madison 
Wisconsin) following the user’s manual recommendations. 
The purified DNA was quantitated by ultraviolet absorbance 
spectrophotometry (NanoPhotometerTM spectrophotometer, 
Implen GmbH, Germany) at 260 nm. Additionally, DNA pu-
rity was estimated by measuring the A260/A280 ratio, which 
was >1.7. 
2 .  H L A  t Y P I N G
HLA class I (HLA-A*, -B*, -Cw*) and class II (HLA-
DRB1*, -DQB1*, -DPB1*) low-resolution (two digits) 
and high-resolution typing (four digits) was performed by 
well-established techniques: polymerase chain reaction-
sequence specific oligonucleotide probes (PCR-SSOP) and/
or -sequence specific primers (-SSP).16,17 In particular, for 
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PCR-SSOP methodology (multiplex bead array assay) com-
mercial kits provided by One Lambda Inc., (Canoga Park, 
CA, USA), and for PCR-SSP technique commercial kits 
provided by Life Technologies and Olerup Corp. were used, 
according to the instructions provided by the manufacturer.18 
PCR was performed using TECHNE TC-412 thermal cycler 
(Techne Inc. Burlington, USA). HLA data were acquired on 
a dedicated flow cytometry-based platform (Luminex 100 IS, 
Inc.) for SSOP methodology, or electrophoretic mobility of 
targeted sequences on agarose gel 2% for SSP methodology. 
The majority of HLA Class I alleles can be discriminated by 
their exon 2 and 3 sequence, and for Class II alleles, exon 2 
is generally sufficient. Amplified HLA DNA fragments were 
analyzed with HLA Fusion 3.0 software (bead array) or SSP 
UniMatch 6.0, Helmberg-Start Score™ (SSP methodology) 
for automatic allele determination. 
3 .  A s t r s  t Y P I N G
DNA samples were co-amplified at 15 aSTRs DNA mark-
ers namely, D3S1358, HUMTH01, D21S11, D18S51, Penta E, 
D5S818, D13S317, D7S820, D16S539, HUMCSF1PO, Penta 
D, HUMvWA, D8S1179, HUMTPOX, HUMFGA and the 
sex determining Amelogenin marker HUMAMEL, using the 
PowerPlex® 16 multiplex system. The characteristics of the 15 
aSTR loci are shown in Table 1. 5-10ng of diluted target DNA 
were amplified using PowerPlex® HS 5X master mix including 
hot-start Taq DNA polymerase and PowerPlex® 16 HS 10X 
primer pair mix. Multiplex PCR reactions were carried out in 
TECHNE Rrime/elite/02 thermal cycler following the proce-
dure recommended by the manufacturer (Promega, Madison, 
WI, Technical Manual PowerPlex® 16 HS System).19 Then, 1μl 
of fluorescently labeled PCR product was heat denatured in 
9μl of Hi-Di™ formamide (Applied Biosystems, Weiterstadt, 
Germany) containing Internal Lane Standard 600 (Promega 
Corp,) molecular marker, before electrokinetic injection to 
the ABI3130 Genetic Analyzer (Applied Biosystems).20 In 
parallel, an allelic ladder (PowerPlex® 16 HS AL) for each 
STR locus containing all the most common alleles present in 
the Caucasian population was injected in the genetic analyzer. 
As separation matrix performance optimized polymer (POP-
4™ polymer, Applied Biosystems) was used. Raw data were 
further analyzed with GeneMapper® IDX1.3 software for 
automatic allele calling/STR profiles (Applied Biosystems, 
Foster City CA).
4 .  s t A t I s t I c A L  A N A LY s I s
The HLA and aSTRs results within each trio or duo case 
were compared and a determination of inclusion or exclusion 
of the alleged father was made for each HLA and aSTR locus. 
Several statistical methods have been proposed to perform 
parentage analyses using data of HLA and aSTR genetic 
markers.21,22 In this study for HLA analysis the Essen-Möller 
value has been applied.23 For inclusion, in complete trios and 
motherless cases, the statistical parameters paternity index (PI) 
and probability of paternity (W %) were calculated based on 
HLA allele frequency of Greek population database.24,25 The 
W value is attributed by the equation W=PI/1+PI for each 
alleged father (AF), where PI tells how many times more easily 
the observed results are explained by relationship rather than 
by coincidence, using a prior probability of 0.5. According to 
the Essen Möller values obtained, different probability of 
paternity categories were estimated, as follows: <95%, non-
useful; 95.1% to 99.0%, likely; 99.1% to 99.75%, extremely 
likely; 99.76% to 99.99%, practically proved. 
For aSTRs analysis the statistical parameters combined 
paternity index (CPI) and probability of paternity (W) were 
calculated based on equations provided by Buckleton et al 
(2005)26 in order to express the value of evidence, using STRs 
allele frequency of the Greece population published by the 
Laboratory of Forensic Medicine and Toxicology, School of 
Medicine of Thessaloniki.27 PI is a statistical measure of how 
powerfully a match at a particular marker indicates paternity. 
The CPI value was calculated by multiplication of the PI values 
for all fifteen loci. The CPI indicates the overall probability 
of an individual being the biological father of the tested child 
as related to any random man from the entire population of 
the same race. Using the combined value of PI, we calculated 
the W value as follows: W=CPI×0.5/[CPI×0.5+(1-0.5)]=CPI/
CPI+1, for each AF using a prior probability of 0.5.28 The CPI 
and W values were interpreted according to the guidelines and 
recommendations of the International Society for Forensic 
Genetics (ISFG).29-31 Additionally, in order to create pedigrees 
and calculating the W value, the “Familias” program (down-
load free at http://www.nr.no/familias) was used.
r E s U L t s
Fifty paternity cases, previously examined by HLA typing, 
were additionally analyzed by aSTR technology. The results 
of the HLA and the STR analysis from the mother, child, and 
the AF were examined for inheritance of alleles. If the AF was 
indeed the biological father, the child would share one allele 
with the mother and one allele with the father at each tested 
marker (barring mutations). Incompatibilities in at least one 
HLA allele between parents and offspring indicated exclusion, 
while for aSTR DNA typing paternity was excluded in cases 
where apparently paternally inherited alleles were not present 
in at least two aSTR loci, due to the high rate of mutations. 
In summary, 15 out of 50 cases (30%, 12 trios, and 3 moth-
erless cases) were sufficient for exclusion of fatherhood by both 
approaches. For HLA analysis, exclusion was confirmed on 
at least one HLA locus (one trio case), while four exclusions 
were documented on five HLA loci. Exclusion on all six HLA 
loci was not found in any trio or duo case. The highest number 
of exclusions was observed at HLA-A* locus (10 cases) as 
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TABLE 1. Information on 16 commonly used autosomal STR loci present in PowerPlex® 16 multiplex system com-
mercial kit.





Repeat Numbers of Allelic Ladder
Components*




Penta E 15q AAAGA 5-24 379-474 FL#
D18S51 18q21.3 AGAA (22) 8-10, 10.2, 11-13, 13.2, 14-27 290-366 FL
D21S11 21q11-21q21 TCTA 
Complex (22)
24, 24.2, 25, 25.2, 26-28, 28.2, 29, 29.2, 30, 
30.2, 31, 31.2, 32, 32.2, 33, 33.2, 34, 34.2, 
35, 35.2, 36-38
203-259 FL
TH01 11p15.5 AATG(22) 4-9, 9.3, 10-11, 13.3 156-195 FL





16-18, 18.2, 19, 19.2, 20, 20.2, 21, 21.2, 
22, 22.2, 23, 23.2, 24, 24.2, 25, 25.2,  
26-30, 31.2, 43.2, 44.2, 45.2, 46.2
322-444 TMR†
TPOX 2p24-2pter AATG 6-13 262-290 TMR






Amelogenin Xp22.1-22.3 Y NA X, Y 106, 112 TMR
Penta D 21q AAAGA 2.2, 3.2, 5, 7-17 376-449 JOE§
CSF1PO 5q33.3-34 AGAT 6-15 32-357 JOE
D16S539 16q24.1 GATA 5, 8-15 264-304 JOE
D7S820 7q11.21-22 GATA 6-14 215-247 JOE
D13S317 13q22-q31 TATC 7-15 176-208 JOE
D5S818 5q23.3-32 AGAT 7-16 119-155 JOE
*Report published at the U.S. National Institute of Standards and Technology (NIST) web site at: www.cstl.nist.gov/div831/strbase/ 
† carboxy-tetramethylrhodamine (TMR) 
§ 6-carboxy-4´,5´-dichloro-2´,7´-dimethoxy-fluorescein (JOE) 
# fluorescein (FL)
opposed to HLA-DPB1* (6 cases). On the other hand, HLA 
data agreed with the results reported using analysis of aSTR 
genetic polymorphism both for inclusion and exclusion. More 
specifically, in all cases, exclusion was confirmed on at least 
five genetic aSTR loci (one duo case), while evidence for one 
exclusion was obtained by twelve loci, whereas exclusion based 
on 15 aSTR loci was not observed in any case. The most pow-
erful excluding locus of the PowerPlex® 16 multiplex system 
kit was D21S11 and D18S51 with 11 exclusions each, followed 
by D3S1358 and D16S539 (10 exclusions each), Penta E, 
D13S317, and FGA (9 each), D7S820, Penta D, and D8S1179 
(8 each), THO1, CSFIPO and TPOX (7), while D5S818 (6) 
and vWA (5) turned out to be the least informative loci. Fig-
ure 1 illustrates the number of cases in which exclusions were 
observed for various numbers of HLA and STR loci, while 
the distribution of exclusions for each HLA and STR locus is 
presented in figure 2. 
In all remaining 35 non-exclusion analyzed cases, the AF 
could be determined as the biological father. All cases gave 
STR probability statistics closer to 100% than did the HLA 
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FIGUrE 1. Comparison of the rate of mismatch for all HLA and STR loci concluded from 15 excluded paternity cases. 
probabilities calculated. The PI value for the 35 non-excluded 
cases using HLA genotyping ranged from 76 to 6,452,794, 
whereas using aSTR genotyping ranged from 15,173 to 
9.2×1010. Additionally, the W rates ranged from 98.69990663% 
to 99.99998145% using HLA genotyping were increased to 
99.99999999% using aSTR analysis. The results are sum-
marized in table 2. A comparison with the probabilities of 
paternity calculated for the alleged father of each matching 
trio or duo based on HLA and aSTR data is given in figure 3. 
Furthermore, concerning CPI values between paternity trios 
and duo cases calculated by STR, statistically significant dif-
ference was observed. 
In general, using aSTR loci CPI values were estimated to 
be >105 in all inclusion paternity trios cases and >106 in 96% 
of the inclusion paternity trios cases, whereas CPI values of 
the inclusion paternity duos cases were estimated to be >106 
in only 10% of the tested cases (Table 3). 
In conclusion, our data show that the core of 15 aSTR 
loci gave acceptable results, as 100% of cases gave CPI values 
>10,000 and it is in accordance to the global guidelines, where 
FIGUrE 2. The distribution of STR and HLA loci according to the number of exclusions. For parentage investigations, three exclud-
ing STR loci are required to prove non-paternity. Additionally, incompatibilities in at least one HLA allele between parents and 
offspring indicate exclusion.
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TABLE 2. The paternity index (PI), the combined paternity index (CPI), and the probability of paternity (W) by HLA 
and STR loci respectively for twenty-five trio and ten duo (motherless cases) non-excluded paternity cases. 
Case no Case type PI by HLA* W by HLA (%) CPI by STRs W by STRs (%)
Case 1 Trio 5,390,081 99.99998145 517,054,819 99.99999981
Case 2 Trio 152 99.34595638 714,736 99.99986009
Case 3 Trio 76 98.70041262 5,710,242 99.99998249
Case 4 Trio 84,220 99.99881265 1,009,541 99.99990094
Case 5 Trio 3875 99.97420098 113,311,778 99.99999912
Case 6 Trio 304 99.67190525 5,072,937 99.99998029
Case 7 Trio 8300 99.98795322 90,512,864 99.99999889
Case 8 Trio 642 99.84451514 91,657,841,253 99.99999999
Case 9 Trio 2465 99.95944137 6,507,788 99.99998463
Case 10 Trio 70,982 99.99859121 1,371,661,427 99.99999993
Case 11 Trio 162,738 99.99938552 48,943,755 99.99999796
Case 12 Trio 224,578 99.99955472 7,039,306 99.99998579
Case 13 Trio 11,142 99.99102551 77,275,750 99.99999871
Case 14 Trio 45,069 99.99778124 15,322,435 99.99999347
Case 15 Trio 21,891 99.99543203 3,635,636 99.99997249
Case 16 Trio 76 98.69990663 5,826,893 99.99998284
Case 17 Trio 897 99.88858005 470,473,480 99.99999979
Case 18 Trio 3356 99.97021558 59,709,569 99.99999833
Case 19 Trio 72,893 99.99862815 34,852,378 99.99999713
Case 20 Trio 173 99.42537659 9,268,964 99.99998921
Case 21 Trio 11,088 99.99098196 7,508,945 99.99998668
Case 22 Trio 2,089,890 99.99995213 49,429,109 99.99999798
Case 23 Trio 6,452,794 99.99998450 2,247,801 99.99995551
Case 24 Trio 28,466 99.99648718 3,817,747 99.99997381
Case 25 Trio 51,320 99.99805149 2,345,470 99.99995736
Case 26 Duo 4497 99.97776811 31,986 99.99687373
Case 27 Duo 4497 99.97776811 128,456 99.99922153
Case 28 Duo 4779 99.97908034 965,787 99.99969646
Case 29 Duo 2210 99.95476452 118,540 99.99915641
Case 30 Duo 72,366 99.99861815 529,736 99.99981123
Case 31 Duo 659 99.84839830 15,173 99.99340978
Case 32 Duo 665 99.72684949 190,507 99.99947509
Case 33 Duo 5654 99.98231744 207,965 99.99951915
Case 34 Duo 5654 99.98231744 8,775,980 99.99998861
Case 35 Duo 481 99.79248510 67,829 99.99852573
* PI by HLA corresponds to CPI by STRs
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CPI of 10,000 is recommended as minimal for fatherhood 
determination.
U N E X P E c t E D  O b s E r VA t I O N s
Among 35 parent/child allele transfers at 15 aSTR loci, 
where the paternity is not excluded using aSTR loci, one AF 
showed one genetic discrepancy with the child at D21S11 locus 
(case 32), the most heterozygous and complex locus, which was 
scored as inconclusive result. It was a case where the mother 
was missing from the triplet (motherless case) (Fig. 4 and 5). In 
practice, one locus mismatch is considered as a mutation event 
and is therefore ignored. Statistical analysis was conducted con-
sidering the 14 remaining loci only. The D21S11 incompatibility 
was classified as a repeat loss single-step mutation (putative mu-
tation 31→30) or double-step mutation (31→29), possibly as a 
result of slippage of the DNA replication complex during DNA 
synthesis. Initially, the motherless case was reanalyzed from 
the original samples to confirm the unexpected result, and as a 
final supplement, full HLA-A*, -B*, -Cw*, -DRB1*, -DQB1*, 
-DPB1 typing and allele subtyping was added. The AF was 
typed as HLA-A*02, *32; -B*18, *27; -Cw*02, *07; -DRB1*11, 
*16; -DQB1*05, *03; -DPB1*02:01,*04:02, while the child in 
FIGUrE 3. Comparison of the probabilities of paternity for the biological father calculated for the 35 inclusion cases. All of the 
tested cases have higher probabilities of paternity for the STR loci in comparison to HLA loci.
TABLE 3. Reported values of paternity index (PI) and the probability of paternity (W) for 35 paternity trios and mother-
less cases using HLA and aSTR genetic polymorphism respectively.
PI-values W-values Families by HLA (%)
N=35
Families by STR (%)
N=35
Trio & Motherless cases* Trio cases (N=25) Motherless cases (N=10)
<100 <99% 5.71 0 0
100-1000 99-99.9% 22.86 0 0
1000-10,000 99.9-99.99% 28.57 0 0
10,000-100,000 99.99-99.999% 28.57 0 30
100,000-1,000,000 99.999-99.9999% 5.71 4 60
>1,000,000 >99.9999% 8.57 96 10
* The W value is the same in both trio and motherless cases as the calculated equation does not take into account the genotype of the mother.
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question was typed as HLA-A*03,*32; -B*18,*35; -Cw*04, *07; 
-DRB1*11, *15; -DQB1*05, *03; -DPB1*04:01,*04:02. We did 
not rule out fatherhood and a sufficient paternity probability 
was achieved even after the mutation calculation, where CPI 
and W values by aSTR analysis were calculate to be 190,507 and 
99.99947509%, while PI and W values by HLA approach were 
calculate to be 665 and 99.72684949% respectively. This by STR 
calculated probability was sufficient for inclusion of the father. 
However, the probability of paternity for the biological father 
was low by HLA methodology due to the inheritance of very 
common HLA alleles: HLA-A*32, -B*18, -Cw*07, -DRB1*11, 
-DQB1*03, -DPB1*04:02.
DIscUssION 
Nowadays, the application of STR DNA-typing in labora-
tory medicine is increasing rapidly, with uses in paternity and 
FIGUrE 4. Electropherogram data depicting the DNA profile of the alleged father (ID:10874) produced with the PowerPlex® 16 
multiplex system (case 32).
FIGUrE 5. Electropherogram data depicting the DNA profile of the child (ID:10875) produced with the PowerPlex® 16 multiplex 
system. The child share one allele with the alleged father (ID:10874) at each tested STR marker, barring D21S11 STR loci due to 
mutation event (Putative single-step mutation: D21S11 31→30 or double-step mutation 31→29). Paternity is not excluded (case 32). 
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maternity assessment. As the most DNA-typing applications 
frequently have legal and ethical implications, there is a 
particular need for high reliability, and high discrimination 
power.32,33 
Data from the present study lead to the conclusion that 
aSTR genotyping is a powerful tool for the analysis of parent-
age disputes. From the practical perspective, easily performed 
standard methodology with high reproducibility and low cost 
as well as abundance of STR loci in human genome, makes 
them ideal genome markers for paternity/maternity assess-
ment.34,35 Specifically, in all paternity trio cases, 15 forensic loci 
were effective in excluding paternity or sufficient to provide 
positive proof (strong evidence) of paternity, and offer high 
discriminating power with W rate ranged from 99.99340978% 
to 99.99999999%. Using a well-qualified database, we can 
obtain a PI likelihood ratio as high as 106 in usual trio cases. 
Additionally, the application of STR DNA-typing in parentage 
testing provides more flexibility in samples handling and test-
ing, as well as greater discrimination efficiency in comparison 
to conventional HLA genetic typing.
The W value in the trio case is higher than that in the 
motherless cases, and the difference becomes higher when the 
paternal obligatory alleles are presented with high frequency 
in the population study.
It should be noted that, motherless case results are usu-
ally reliable, although the absence of the mother’s genotype 
increases the possibility of false paternity inclusions, especially 
in cases analyzed with limited number of aSTR loci.36,37 Many 
studies have shown that duo cases were inclusive for pater-
nity, but after consideration of the mother’s DNA typing, the 
kinship was rejected and it was so mainly due to the use of a 
limited number of aSTR loci.38,39 Thus, the laboratory experts 
should include the mother’s genotype in every paternity case. 
If that is impossible, for many reasons, investigation of more 
polymorphic aSTR loci must be considered. In the present 
study the analysis of father-child pairs without investigation of 
the mother resulted in lower likelihood ratios in comparison 
to trio cases, although the W remains higher compared to that 
calculated using HLA typing. 
We emphasize the necessity for greater caution when 
dealing with motherless cases, especially in cases where 
mutation events occur and also in motherless cases with-
out any incompatibilities using a limited number of aSTR 
loci.40,41 In such deficiency cases, where fatherhood cannot 
be confirmed or ruled out with statistical certainty additional 
relatively stable aSTR loci with low mutation rates, or other 
markers (y-STR loci, X-chromosome specific STRs, alter-
native mitochondrial genome (mtDNA) markers) would be 
analyzed in order to include the AF or to reveal additional 
exclusions.42-44 Thereby, every clinical Laboratory involved 
in paternity disputes investigation should have the ability to 
increase the number of analyzed STR loci, or when it is not 
feasible other methods, such as investigation of HLA analysis, 
should be performed in order to come to a sound conclusion 
or exclusion.45
c O N c L U s I O N
The use of DNA-typing with 15 aSTR loci for parentage 
testing provides an accurate and high-sensitivity method which 
is simpler to be performed and more rapid than the accepted 
HLA standard technology. Analysis of aSTR loci offers a highly 
discriminating test suitable for trio paternity testing. It is also 
useful in cases where the maternal DNA is not available, or 
when individuals originate from the same lineage are tested. 
Furthermore, when a mutation event occurs in motherless 
cases, combination of HLA and STR polymorphisms offers 
high level of information and also diminishes the possibility of 
false exclusion due to aSTRs mutations, or minimizes the risk 
of wrong inclusion due to the absence of the mother’s genotype.
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